INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 220 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14 | -6.7% | 35,300 | +5.4% | 0.00% | -50.0% |
| Q2 2023 | $15 | -11.8% | 33,500 | +59.5% | 0.00% | 0.0% |
| Q1 2023 | $17 | -41.4% | 21,000 | +12.3% | 0.00% | -33.3% |
| Q4 2022 | $29 | -99.9% | 18,700 | -39.9% | 0.00% | -50.0% |
| Q3 2022 | $54,000 | +1.9% | 31,100 | +1.5% | 0.01% | -14.3% |
| Q2 2022 | $53,000 | -51.8% | 30,650 | 0.0% | 0.01% | -36.4% |
| Q1 2022 | $110,000 | -23.6% | 30,650 | +6.2% | 0.01% | -8.3% |
| Q4 2021 | $144,000 | -42.4% | 28,851 | -17.5% | 0.01% | -42.9% |
| Q3 2021 | $250,000 | +4.2% | 34,951 | +35.2% | 0.02% | +5.0% |
| Q2 2021 | $240,000 | +10.6% | 25,851 | +10.7% | 0.02% | +17.6% |
| Q1 2021 | $217,000 | +102.8% | 23,351 | +93.8% | 0.02% | +88.9% |
| Q4 2020 | $107,000 | +386.4% | 12,051 | +12.6% | 0.01% | +125.0% |
| Q3 2019 | $22,000 | – | 10,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 648,800 | $1,920,000 | 1.55% |
| Round Table Services, LLC | 339,391 | $998,000 | 0.31% |
| ARK Investment Management | 3,955,017 | $11,628,000 | 0.29% |
| Nikko Asset Management Americas, Inc. | 4,884,100 | $14,359,000 | 0.28% |
| WASATCH ADVISORS LP | 6,735,726 | $19,803,000 | 0.19% |
| Cedar Brook Financial Partners, LLC | 41,500 | $122,000 | 0.06% |
| Unified Trust Company, N.A. | 15,716 | $46,000 | 0.03% |
| Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors | 13,500 | $40,000 | 0.03% |
| STONERIDGE INVESTMENT PARTNERS LLC | 16,914 | $50,000 | 0.02% |
| Sumitomo Mitsui Trust Holdings, Inc. | 4,884,100 | $14,359,000 | 0.01% |